Patient Profiles

Many patients can benefit from PKU GOLIKE

PKU GOLIKE is specially formulated to help children, teens, and adults with PKU, wherever they are on their journey.1,2 Here are some examples:

Women who are pregnant or family planning

Women who are pregnant or family planning

  • Need to maintain a strict diet and supplement with medical foods to reduce their infants’ risk for developmental problems3
  • Granule coating is plant-based and considered safe for pregnant women with PKU4,5
  • Easier to adopt because it has no flavor4
Younger children

Younger children

  • Prepackaged and premeasured to make it easy to take to school or camp
  • Doesn’t have a taste or leave an aftertaste4
  • Can be mixed with a wide variety of foods
  • Doesn’t need to be taken with large volumes of liquid1,2,4
Patients with higher <span class="text-uppercase">BMI</span>

Patients with higher BMI

  • Low-calorie, low-carb, and naturally sugar-free—less than 100 calories and only 3.5 grams of carbs per packet1,2
  • Allows flexibility for patient or caregiver to choose foods to mix with that are appropriate for caloric needs5
Busy families or patients with active lifestyles

Busy families or patients with active lifestyles

  • Prepackaged and premeasured so everyone in the family can get the right amount of vitamins, minerals, and AAs for their age1,2
  • Complies with all TSA requirements and well-suited for travel, the office, and school
AA icon

PKU GOLIKE gives people with PKU all the amino acids they need.

Get more details about our products

References: 1. PKU GOLIKE Plus 16+ Technical Sheet. Relief Therapeutics, 2022. 2. PKU GOLIKE Plus 4-16 Technical Sheet. Relief Therapeutics, 2022. 3. Enns GM, Koch R, Brumm V, et al. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence. Mol Genet Metab. 2010;101(2-3):99-109. 4. MacDonald A, Ashmore C, Daly A, et al. An observational study evaluating the introduction of a prolonged-release protein substitute to the dietary management of children with phenylketonuria. Nutrients. 2020;12(2686):1-11. doi:10.3390/nu12092686 5. Giarratana N, Giardino L, Bighinati A, et al. In vivo metabolic responses to different formulations of amino acid mixtures for the treatment of phenylketonuria (PKU). Int J Mol Sci. 2022;23(2227):1-12. doi:10.3390/ijms23042227